By binding to the TZF region of TTP, PIM2 not only promotes the degradation of TTP protein through the ubiquitin-proteasome pathway, but also inhibits the proliferation and migration of breast cancer cells (60). This evidence concerns the gene ZFP36 and breast carcinoma.